Nuropod has published a clinical research and symptoms guide examining the vagus nerve and POTS connection, giving readers clear explanations of standing heart rate changes, common symptoms and studied stimulation approaches.
-- Nuropod, a wearable vagus nerve stimulation device brand, has published a guide examining the connection between the vagus nerve and postural orthostatic tachycardia syndrome (POTS). The guide covers common symptoms, standing heart rate changes, and findings from clinical research using Parasym's proprietary technology.
More information is available at https://nuropod.com/blogs/articles/vagus-nerve-and-pots-research-symptoms-connection
The announcement reflects increasing attention to POTS, a condition that can make routine activities such as standing, working, and moving more demanding. Nuropod's guide seeks to provide individuals living with POTS, and those supporting them, with a structured overview of the condition and the research conducted in this area.
Research from Advanced Neurology highlights the fact that POTS can be difficult to identify because its symptoms often overlap with other conditions. The Nuropod guide explains the defining feature of POTS - a heart rate that rises and remains elevated upon standing - alongside other common symptoms. It also emphasizes the importance of assessment by a qualified healthcare professional.
The guidance also examines the role of the vagus nerve in this field of research. The vagus nerve carries signals between the brain and organs, including the heart, lungs, and gut, and plays a large part in how the body handles stress, rest, and recovery. In addition, the resource explains the relevance of heart rate variability (HRV), the variation in time between heartbeats, as a measure used in related studies.
Readers will find an overview of how noninvasive vagus nerve stimulation is delivered at the ear, with no implant or procedure required. The article identifies the primary measure used in POTS studies and presents findings from research using the technology developed by Parasym, the research company behind Nuropod.
The guide further outlines how Nuropod is used: an earpiece clips onto the tragus, the small flap of cartilage at the front of the ear, and delivers gentle electrical pulses through the proprietary AVNT™ waveform. It covers typical session length and notes that the device is used alongside existing care, not instead of it. The technology is backed by 10+ years of research and development, 60+ completed clinical studies, and 100+ ongoing clinical studies.
Additional details can be found at https://nuropod.com/
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-significant risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89208977
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.
